Drug intelligence / Profile preview

i-Flex

Development stage
Unknown
Lead developer
Nutrifuel Nutrition
Administration
Oral
01

Overview

i-Flex is a dietary supplement combination consisting of rose hips extract, a berry extract blend (blueberry and blackberry), and Resveravine, a proprietary grapevine extract. It is primarily marketed for the maintenance of joint health and flexibility. The rose hips component is typically standardized for galactolipids (such as GOPO), which are believed to inhibit the chemotaxis of polymorphonuclear leukocytes, thereby reducing joint inflammation. The berry extracts provide anthocyanins, which serve as potent antioxidants to neutralize reactive oxygen species in joint tissues. Resveravine is a specific extract from *Vitis vinifera* (grapevine stalks) that contains high concentrations of trans-resveratrol and viniferins (specifically epsilon-viniferin), which act as anti-inflammatory agents by modulating NF-κB and COX-2 signaling pathways.

Brand names
i-Flex
Other names
rose hips extract + blueberry/blackberry extract + resveravine
02

Targets

SIRT1 (NAD-dependent protein deacetylase sirtuin-1)COX

Beyond the preview

Go deeper on i-Flex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on i-Flex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call